UK Markets close in 6 hrs 52 mins
  • FTSE 100

    7,405.87
    +103.13 (+1.41%)
     
  • FTSE 250

    19,953.66
    +264.64 (+1.34%)
     
  • AIM

    958.21
    +11.04 (+1.17%)
     
  • GBP/EUR

    1.1798
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2471
    -0.0004 (-0.0287%)
     
  • BTC-GBP

    24,301.35
    +860.37 (+3.67%)
     
  • CMC Crypto 200

    675.14
    +22.90 (+3.51%)
     
  • S&P 500

    3,900.79
    -22.89 (-0.58%)
     
  • DOW

    31,253.13
    -236.94 (-0.75%)
     
  • CRUDE OIL

    111.65
    -0.56 (-0.50%)
     
  • GOLD FUTURES

    1,843.20
    +2.00 (+0.11%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    14,057.45
    +175.15 (+1.26%)
     
  • CAC 40

    6,319.78
    +47.07 (+0.75%)
     

Why Sesen Bio Stock Got Slammed Today

·2-min read
Why Sesen Bio Stock Got Slammed Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The biotech, which concentrates on developing treatments for cancer, saw its share price dive by nearly 18% on the day. In August, the company's Biologics License Application (BLA) was rejected by the Food and Drug Administration (FDA). In its press release published just after the meeting, which Sesen Bio characterized as "productive," the company wrote that it now "believes it has greater clarity regarding the requirements for resubmission of the BLA and the trial design."

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting